Gipave graphene asphalt trial in Kent

RNS Number : 9790Q
Directa Plus PLC
25 June 2020
 

25 June 2020

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Gipave graphene asphalt trial in Kent

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company supplied Gipave, the Company's proprietary asphalt supermodifier, for use in a road trial in Kent, United Kingdom starting this month

 

Directa is working in collaboration with its industrial partner Iterchimica and Kent County Council, to resurface an existing road on East Hill, Dartford.

 

This follows previously announced trials in Rome, Italy, and in Oxfordshire, United Kingdom, which showed that Gipave increases the lifespan and durability of road surfaces, through the addition of a G+ graphene super modifier.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "Directa's vision is to use graphene technology to enhance existing products, to provide better outcomes for end users. Gipave is an excellent example of the products Directa produces, it allows for stronger, more durable road surfaces, and is fully recyclable. The wide adoption of Gipave road surfaces will reduce the long term financial and environmental costs of road construction for drivers and local governments alike."

-ends-

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies, Will Goode(Corporate Finance)

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products.  All our products are hypoallergenic, non-toxic and sustainably produced.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASEUFLLESSELM
UK 100

Latest directors dealings